GPT and hypertriglyceridemia: Twelver patients (7.1%) showed mild transient hyperglycemia (range 127–147 mg/dL, n.v. 60–100 mg/dL); 7 patients (4.2%) showed hypertriglyceridemia (range 181–211 mg/dL, n.v. 45–175 mg/dL); and 9 patients (5.4%) showed an elevation of liver enzymes (5 patients: GPT—range 50–84 U/L, n.v. 0–46 U/L and GOT—range 78–120, n.v. 0–39 U/L; 4 patients: γ-GT—range 42–88 U/L, n.v. 11–40 U/L).